Fondren Management’s Harte-Hanks HHS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-545,502
Closed -$1.66M 19
2020
Q2
$1.66M Buy
545,502
+27,674
+5% +$65.4K 6.41% 7
2020
Q1
$813K Sell
517,828
-44,374
-8% -$132K 2.07% 13
2019
Q4
$2.01M Hold
562,202
2.06% 11
2019
Q3
$1.72M Buy
562,202
+35,799
+7% +$113K 1.43% 19
2019
Q2
$1.16M Hold
526,403
1.1% 27
2019
Q1
$1.88M Buy
526,403
+37,303
+8% +$130K 1.5% 19
2018
Q4
$1.18M Sell
489,100
-96,500
-16% -$460K 1.55% 17
2018
Q3
$4.17M Buy
585,600
+1,500
+0.3% +$13.2K 3.75% 8
2018
Q2
$6.48M Buy
584,100
+119,300
+26% +$1.22M 4.97% 5
2018
Q1
$4.26M Buy
464,800
+171,476
+58% +$1.57M 5.39% 5
2017
Q4
$2.78M Buy
293,324
+117,524
+67% +$1.18M 1.96% 11
2017
Q3
$1.88M Buy
175,800
+37,000
+27% +$341K 1.51% 17
2017
Q2
$1.43M Buy
138,800
+14,300
+11% +$180K 1.56% 15
2017
Q1
$1.74M Sell
124,500
-2,500
-2% -$38.1K 1.87% 15
2016
Q4
$1.92M Buy
+127,000
New +$1.92M 1.37% 20

Other funds holding HHS

Fondren Management's HHS Position: Q3 2020 in Review

Fondren Management sold out of Harte-Hanks (HHS) in Q3 2020, closing a stake of 545,502 shares — an estimated $1.66M sold.

Fondren Management first reported a position in HHS in Q4 2016 and held it in 15 quarters. The position peaked at $6.48M in Q2 2018. 6 funds tracked by Wall St. Rank hold HHS as of Q3 2020.

  • Fondren Management reported no remaining Harte-Hanks position as of Q3 2020 after selling out during the quarter.
  • Fondren Management sold 545,502 Harte-Hanks shares in Q3 2020, an estimated $1.66M.
  • Fondren Management first reported a position in Harte-Hanks in Q4 2016 and held it in 15 quarters.
  • Fondren Management's Harte-Hanks position peaked at $6.48M in Q2 2018.
  • 6 funds tracked by Wall St. Rank held Harte-Hanks as of Q3 2020.

Based on Fondren Management's 13F filing for Q3 2020, filed 13 Nov 2020.